Chalmers Ventures Invests in Bioelectrix
Chalmers Ventures invests in Bioelectrix – groundbreaking technology to treat hard-to-heal wounds Bioelectrix is a new portfolio company at Chalmers Ventures. The company is taking on a global health problem—hard-to-heal wounds—by developing a solution that, using electrical stimulation and advanced, cost-effective materials, can steer skin cells back into the healing process. “This is a silent […]